Lymphadenectomy for gastric carcinoma;Stellenwert der lymphadenektomie im behandlungskonzept des magenkarzinoms

Viszeralchirurgie

Volumn 40, Issue 4, 2005, Pages 272-278

  Mönig, Stefan P ^a   Bollschweiler, E ^a   Holscher A H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Gastric carcinoma; Lymphadenectomy; Prognostic factors; Surgical morbidity

Indexed keywords

ADVANCED CANCER; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORBIDITY; PANCREAS RESECTION; PROGNOSIS; REVIEW; SAFETY; SPLENECTOMY; STOMACH CARCINOMA; SURGICAL MORTALITY;

EID: 23844472301     PISSN: 14353067     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836648     Document Type: Review

References (62)

1. Arak A, Kull K. Factors influencing survival of patients after radical surgery for gastric cancer. A regional study of 406 patients over a 10-year period. Acta Oncol 1994; 33: 913-920
2. Bollschweiler E, Boettcher K, Hölscher AH et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 1993; 71: 2918-2925
3. Bonenkamp JJ, Songun I, Hermans J et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748
4. Bonenkamp JJ, Hermans J, Sasako M, de Velde CJ van. Extended lymph-node dissection for gasteric cancer. Dutch gastric cancer group. NEJM 1999; 340: 908-914
5. Bozzetti F, Marubini E, Bonfanti G et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg 1997; 226: 613-620
6. Brennan MF. Lymph node dissection for gastric cancer. NEJM 1999; 340: 956-958
7. Bunt AMG, Hogendorn PCW, de Velde CJH, Bruijn JA van, Hermans J. Lymph node staging standards in gastric cancer. J Clin Oncol 1995; 13: 2309-2316
8. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002; 131: 401-407
9. Cuschieri A, Fayers P, Fielding J et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 1996; 347: 995-999
10. Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 1999; 79: 1522-1530
11. De Almeida JC, Bettencourt A, Costa CS, de Almeida JM. Curative surgery for gastric cancer: study of 166 consecutive patients. World J Surg 1994; 18: 889-894
12. Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90: 1727-1732
13. Edwards P, Blackshaw GRJC, Lewis WG et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 2004; 90: 1888-1892
14. Faß J, Hungs M, Reineke T, Nachtkamp J, Schumpelick V. Zur Frage der Prognoseverbesserung durch R1- und R2-Lymphadenektomie beim Magenkarzinom. Chirurg 1994; 65: 867-872
15. Gall FP, Hermanek P. Die systematische Lymphknotendissektion in der kurativen Therapie des Magenkarzinoms. Chirurg 1993; 64: 1024-1031
16. Gretschel S, Bembenek A, Ulmer C et al. Lymphatic mapping und Sentinel-Lymphknotendiagnostik beim Magenkarzinom. Chirurg 2003; 74:132-138
17. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brenann MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002; 131: 6-15
18. Hartgrink HH, de Velde CJH van, Putter H et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized dutch gastric cancer group trial. JCO 2004; 22: 2069-2077
19. Hermanek P. Lymphadenectomy: pathological aspects. Langenbecks Arch Chir Ver Dtsch Ges Chir 1996; 113 (Suppl II): 64-69
20. Hermanek P. Lymph nodes and malignant tumor disease. Zbl Chir 2000; 125: 790-795
21. Hölscher AH, Bollschweiler E. Ausmaß von Resektion und Lymphadenektomie beim Magenkarzinom - eine anhaltende Kontroverse. Onkologe 1998; 4: 301-309
22. Huscher CG, Mingoli A, Sgarzini G et al. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer. Am J Surg 2004; 188: 728-735
23. nd English edition. Gastric Cancer 1998; 1: 10-24
24. th Report of nationwide registry. 1995
25. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10 year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995; 76: 1302-1312
26. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? Ann Surg 2000; 232: 362-371
27. Kitagawa Y, Fujii H, Mukai M, Kuboto T, Otani Y, Kitajima M. Radio-guided sentinel node dissection for gastric cancer. Br J Surg 2002; 89: 604-608
28. Kitagawa Y, Burian M, Kitajima M. Zur Methodik des Sentinel Lymph Node Mapping. Chirurg 2004; 75: 751-755
29. Kodera Y, Yamamura Y, Torii A et al. Postoperative staging of gastric carcinoma. Scand J Gastroenterol 1996; 31: 476-480
30. Kodera Y, Yamamura Y, Shimizu Y et al. Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma. World J Surg 1997; 21: 622-627
31. Lee WJ, Lee WC, Houng SL et al. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg 1995; 19: 707-725
32. Lewis WG, Edwards P, Barry JD et al. D2 or not D2? The gastrectomy question. Gastric Cancer 2002; 5: 29-34
33. Lisborg P, Jatzko G, Horn M et al. Radical surgery (R2 resection) for gastric cancer. A multivariate analysis. Scand J Gastroenterol 1994; 29: 1024-1028
34. Llanos O, Guzman S, Pimental F, Ibanez I, Duarte I. Results of surgical treatment of gastric cancer. Dig Surg 1999; 16: 385-388
35. Maehara Y, Tomoda M, Tomisaki S et al. Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997; 121: 633-639
36. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Post-operative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000; 87: 353-357
37. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 198; 210: 596-602
38. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adeneocarcinoma of the stomach (Review). Cochrane Database Syst Rev 2004; 18: CD001964
39. Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A. Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 2003; 90: 178-182
40. Mönig SP, Zirbes TK, Schröder W et al. Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. Am J Roentgenol 1999; 173: 365-367
41. Mönig SP, Collet PH, Baldus SE et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 2001; 76: 89-92
42. Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989; 64: 2053-2062
43. Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM. Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000; 7: 210-217
44. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993; 80: 1153-1156
45. Roder JD, Boettcher K, Siewert JR. Results of the German Gastric Cancer Study, multivariate analysis of potentially factors of 1654 resected patients. In: Nishi M, Sugano H, Takahashi T (Eds). International Gastric Cancer Congress. Monduzzi Editore, Bologna, Italy 1995; 47-54
46. Roukos DH, Baltogiannis G, Cassioumis D. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1995; 82: 1287-1289
47. Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer base on a new concept: a prospective long-term follow-up study. Surgery 1998; 1253: 573-578
48. Sano T, Sasako M, Yamamoto S et al. Gastric cancer surgery: morbidity and mortality results from a prospective controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501. JCO 2004; 14: 2767-2773
49. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995; 82: 346-351
50. Schmidt-Matthiesen A, Beyer PA. Intraoperative macroscopical evaluation of lymph node metastases in gastric cancer patients. Zbl Chir 1996; 121: 121-125
51. Sendler A, Etter M, Böttcher K, Siewert J. Resektionsausmaß in der Chirurgie des Magenkarzinoms. Chirurg 2002; 73: 316-324
52. Shchepotin I, Evans SR, Shabahang M et al. Radical treatment of locally recurrent gastric cancer. Am Surg 1995; 61: 371-376
53. Sierra A, Regueira FM, Hernandez-Lizoain JL, Pardo F, Martinez-Gonzalez MA, A-Cienfueges J. Role of extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 2003; 10: 219-226
54. Siewert JR, Boettcher K, Roder J, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993; 80: 1015-1018
55. Siewert JR, Stein HJ, Böttcher K. Lymphadenektomie bei Tumoren des oberern Gastrointestinaltraktes. Chirurg 1996; 67: 877-888
56. Siewert JR, Kestlmeier B, Busch R et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83: 1144-1147
57. Siewert JR, Böttcher K, Stein H, Roder JD. Relevant prognostic factors in gastric cancer. Ann Surg 1998; 228: 449-461
58. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. Sixth Edition. Wiley-Liss, New York 2002; 65-68
59. Tonouchi H, Mohri Y, Tanaka K et al. Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig Surg 2003; 20: 421-427
60. Wanebeo HJ, Kennedy BJ, Chmiel J, Steele G, Wichester D, Osteen R. Cancer of the stomach, a patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592
61. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91: 283-287
62. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002; 9: 771-774